Ledger.Open graph →
SEC Form D · filed January 26, 2015

IGENICA BIOTHERAPEUTICS, INC

Offering
$6.3M
Sold
$5.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BURLINGAME, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

John Diekman · Menlo Park, CADirectorMark Goldsmith · Burlingame, CADirectorRobert Schreiber · Burlingame, CADirectorDavid Goeddel · San Francisco, CADirectorCarl Gordon · New York, NYDirectorJohn Celebi · Burlingame, CAExecGwen Fyfe · Burlingame, CADirectorMathias Schilling · San Francisco, CADirectorErnst Bergen · Lemont, ILDirectorDavid Kushner · New York, NYDirectorAndrew N. Dakos · Saddle Brook, NJDirectorChris Dimock · Cody, WYDirectorCustodial Trustee The Northern Trust Company · Chicago, ILDirectorRyan Rients · SIOUX FALLS, SDExec · DirectorMartin Jaszczuk · Lemont, ILExecDavid Rowe · Boca Raton, FLDirectorKeval Desai · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗